Global Biomarkers Market Growth Analysis 2024, Forecast To 2033
15 Feb, 2024
The biomarkers market has exhibited rapid growth, climbing from $61.31 billion in 2023 to $69.54 billion in 2024, reflecting a compound annual growth rate (CAGR) of 13.4%. Factors contributing to historical growth encompass advances in genomics and proteomics technologies, the prevalence of chronic diseases, personalized medicine focus, and increased use in drug development. Forecasts project significant expansion, reaching $117.82 billion in 2028, propelled by a heightened emphasis on early disease detection, biomarkers' role in oncology and immunotherapy, precision medicine investments, and the rise of non-invasive biomarker detection methods. Noteworthy trends include multi-biomarker panels and exploration of exosome-based and point-of-care biomarker testing.
Global Biomarkers Market Key Driver
The increase in heart diseases is expected to propel the growth of the biomarkers market. The rising incidence of cardiovascular risk factors, such as diabetes, dyslipidemia, hypertension, and obesity, is projected to lead to an increase in heart diseases. Biomarkers, including natriuretic peptides and high-sensitivity C-reactive protein, are increasingly used for heart disease diagnosis and management.
Get A Free Sample Of The Global Biomarkers Market ReportGlobal Biomarkers Market Segments
The biomarkers market covered in this report is segmented –
1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers
2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases
3) By Type: Biomarker Of Exposure, Biomarker Of Diseases
4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies
5) By Application: Risk Assessment, Development of Molecular Diagnostic, Disease Diagnosis, Drug Discovery And Development, Drug Formulation, Forensic Application, Other Applications (DNA Fingerprinting And Others )
By Geography: The regions covered in the template market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
North America was the largest region in the biomarkers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Biomarkers Industry Players
Enzo Biochem Inc; Bio-Rad Laboratories Inc.; Merck KGaA; PerkinElmer Inc.; QIAGEN N. V.; Adaptive Biotechnologies Corp.; Agilent Technologies Inc.; Biocrates Life Sciences AG; BioFire Diagnostics LLC; BioReference Laboratories Inc.; Bio-Techne Corporation; Cepheid Inc.; Eurofins Scientific SE; Exact Sciences Corporation; Foundation Medicine Inc.; Genomic Health Inc.; GenScript Biotech Corporation; Guardant Health Inc.; Illumina Inc.; Invitae Corporation; Laboratory Corporation of America Holdings; Luminex Corporation; Metabolon Inc.; Myriad Genetics Inc.; Natera Inc.; Pacific Biosciences of California Inc.; Quest Diagnostics Incorporated; Roche Diagnostics Corporation; Thermo Fisher Scientific Inc.; Veracyte Inc.
Get The Full Global Biomarkers Market Report
Biomarkers Market Overview
Biomarkers refer to a biological molecule that is a marker for a condition, disease, or aberrant process and can be discovered in tissues, body fluids, or blood. It is used to determine how well the body responds to a disease or condition's treatment. These biomarkers have a clinical role in narrowing or guiding treatment decisions.
Biomarkers Global Market Report 2023 provides data on the global biomarkers market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The biomarkers market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.